drugset / Trial / NCT02788864

Prevention of Malaria With Dihydroartemisinine + Piperaquine for Forest Rangers

NCT02788864 ↗

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of the study is to assess if the antimalarial drugs Dihydroartemisinine + Piperaquine (DP) are effective in preventing malaria infection for forest ranger

Timeline

Start
2016-05-20
Primary completion
2016-11-30
Completion
2016-11-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Arterakine Unknown 7 mg/kg —
Comparator Arterakine Unknown 40 mg —
Comparator Arterakine Unknown 55 mg/kg —
Comparator Arterakine Unknown 320 mg —

Indications